missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CDX2 Rabbit anti-Human, Clone: CDX2/4394R, Novus Biologicals™
  7. 18659607

CDX2 Rabbit anti-Human, Clone: CDX2/4394R, Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-07446-100ug

 View more versions of this product

Product Code. 18659607

  • 551.00€ / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CDX2 Monoclonal specifically detects CDX2 in Human samples. It is validated for Immunohistochemistry-Paraffin.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CDX2
Monoclonal
0.2 mg/mL
Immunohistochemistry-Paraffin 1 to 2 μg/mL
caudal type homeo box transcription factor 2, caudal type homeobox 2, Caudal-type homeobox protein 2, CDX-3, CDX3caudal type homeobox transcription factor 2, homeobox protein CDX-2
Recombinant fragments and synthetic peptides from human CDX2 protein (exact sequences are proprietary)
100 μg
Cancer, Chromatin Research, DNA Repair, Growth and Development, Transcription Factors and Regulators
1045
Store at 4°C.
IgG
Immunohistochemistry (Paraffin)
CDX2/4394R
Unconjugated
10 mM PBS with 0.05% BSA
Rabbit
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.